Vermillion has filed to offer more than 2 million shares of its common stock to raise up to $17.3 million.

In a Form S-1 filed this week with the US Securities and Exchange Commission, it said it plans to offer up to 2,098,539 shares of its stock at maximum price of $8.22 per share. The company's stock price has surged in recent months, hitting $8.95 per share on Dec. 27, nearly double its 52-week low of $4.79 on Nov. 30, 2010. It ended the week at $7.64.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.